Brief: Nrx Pharmaceuticals Announces Advance Of $5 Million Milestone Payment From Partners

NRX Pharmaceuticals

12/02/2024 13:36

Feb 12 (Reuters) - NRX Pharmaceuticals Inc  NRXP.O :
    * NRX PHARMACEUTICALS, INC. (NASDAQ: NRXP) ANNOUNCES ADVANCE
OF $5
MILLION MILESTONE PAYMENT FROM PARTNERS ALVOGEN, INC. AND LOTUS
PHARMACEUTICAL CO. LTD. (1975.TW)
    * COS CONTINUE TO WORK COLLABORATIVELY TO ADVANCE NRX-101
THROUGH
REGISTRATIONAL TRIALS
    * REMAINS ELIGIBLE FOR ADDITIONAL $324 MILLION IN
DEVELOPMENT,SALES MILESTONES, TIERED DOUBLE-DIGIT ROYALTIES ON
APPROVAL & COMMERCIALIZATION OF NRX-101
    * PAYMENT MATERIALLY EXTENDS COMPANY'S CASH RUNWAY
    * IN UPDATED AGREEMENT,CO WILL RECEIVE $5 MILLION OF FIRST
MILESTONE,WHICH CO WILL USE TO FUND DEVELOPMENT OF NRX-101
THROUGH PHASE 2 MEETING WITH FDA

Source text for Eikon:  ID:nPn2T0jzCa 
Further company coverage:  NRXP.O 

 ((Reuters.Briefs@thomsonreuters.com;))